{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:37:08Z","timestamp":1792003028088,"version":"4.4.0"},"reference-count":44,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Federal Share of Program income earned by Massachusetts General Hospital","award":["C06 CA059267"],"award-info":[{"award-number":["C06 CA059267"]}]},{"name":"Proton Therapy Research and Treatment Center","award":["C06 CA059267"],"award-info":[{"award-number":["C06 CA059267"]}]},{"name":"Prostate Cancer Foundation","award":["C06 CA059267"],"award-info":[{"award-number":["C06 CA059267"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Purpose: Given that the current standard of proton therapy (PT) for prostate cancer is through bilateral beams, this modality is typically avoided when it comes to treatment of patients with hip prosthesis. The purpose of this study was to evaluate whether novel PT methods, i.e., anterior proton beams and proton arc therapy (PArc), could be feasible options to treat this patient subpopulation. We evaluate PT methods in the context of dosimetry and robustness and compare with standard of practice volumetric modulated arc therapy (VMAT) to explore any potential benefits. Methods: Two PT and one VMAT treatment plans were retrospectively created for 10 patients who participated in a clinical trial with a weekly repeat CT (rCT) imaging component. All plans were robustly optimized and featured: (1) combination anterior oblique and lateral proton beams (AoL), (2) PArc, and (3) VMAT. All patients had hydrogel spacers in place, which enabled safe application of anterior proton beams. The planned dose was 70 Gy (RBE) to the entire prostate gland and 50 Gy (RBE) to the proximal seminal vesicles in 28 fractions. Along with plan dose\u2013volume metrics, robustness to setup and interfractional variations were evaluated using the weekly rCT images. The linear energy transfer (LET)-weighted dose was evaluated for PArc plans to ensure urethra sparing given the typical high-LET region at the end of range. Results: Both PT methods were dosimetrically feasible and provided reduction of some key OAR metrics compared to VMAT except for penile bulb, while providing equally good target coverage. Significant differences in median rectum V35 (22\u201325%), penile bulb Dmean (5 Gy), rectum V61 (2%), right femoral head Dmean (5 Gy), and bladder V39 (4%) were found between PT and VMAT. All plans were equally robust to variations. LET-weighted dose in urethra was equivalent to the physical dose for PArc plans and hence no added urethral toxicity was expected. Conclusions: PT for treatment of prostate cancer patients with hip prosthesis is feasible and equivalent or potentially superior to VMAT in quality in some cases. The choice of radiotherapy regimen can be personalized based on patient characteristics to achieve the best treatment outcome.<\/jats:p>","DOI":"10.3390\/cancers16020330","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T12:56:33Z","timestamp":1704977793000},"page":"330","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Role of Proton Therapy for Prostate Cancer in the Setting of Hip Prosthesis"],"prefix":"10.3390","volume":"16","author":[{"given":"Maryam","family":"Moteabbed","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9409-8680","authenticated-orcid":false,"given":"Mislav","family":"Bobi\u0107","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA"},{"name":"Department of Physics, ETH Zurich, 8093 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6257-2413","authenticated-orcid":false,"given":"Harald","family":"Paganetti","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Efstathiou","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"ref_1","unstructured":"(2023, October 16). American Cancer Society\u2019s (ACS) Publication, Cancer Facts & Figures. Available online: https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2023\/2023-cancer-facts-and-figures.pdf."},{"key":"ref_2","unstructured":"National Cancer Institute (2023, December 25). Prostate Cancer Treatment (PDQ), Available online: https:\/\/www.cancer.gov\/types\/prostate\/hp\/prostate-treatment-pdq."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"20190955","DOI":"10.1259\/bjr.20190955","article-title":"Reduced radiation-induced toxicity by using proton therapy for the treatment of oropharyngeal cancer","volume":"93","author":"Meijer","year":"2020","journal-title":"Br. J. Radiol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Musielak, M., Suchorska, W.M., Fundowicz, M., Milecki, P., and Malicki, J. (2021). Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy. J. Pers. Med., 11.","DOI":"10.3390\/jpm11050410"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jamaoncol.2019.4889","article-title":"Comparative Effectiveness of Proton vs. Photon Therapy as Part of Concurrent Chemoradiotherapy for Locally Advanced Cancer","volume":"6","author":"Baumann","year":"2020","journal-title":"JAMA Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.14338\/IJPT-20-00069.1","article-title":"Proton Radiotherapy to Reduce Late Complications in Childhood Head and Neck Cancers","volume":"8","author":"Spiotto","year":"2021","journal-title":"Int. J. Part. Ther."},{"key":"ref_7","unstructured":"Efstathiou, J. (2023, July 01). Proton Therapy versus IMRT for Low or Intermediate Risk Prostate Cancer (PARTIQoL). Published 12 June 2012, Updated 9 January 2018, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01617161."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"20150195","DOI":"10.1259\/bjr.20150195","article-title":"Intensity modulated proton therapy","volume":"88","author":"Kooy","year":"2015","journal-title":"Br. J. Radiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"20190594","DOI":"10.1259\/bjr.20190594","article-title":"Online daily adaptive proton therapy","volume":"93","author":"Albertini","year":"2020","journal-title":"Br. J. Radiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ijrobp.2016.08.038","article-title":"Reoptimization of Intensity Modulated Proton Therapy Plans Based on Linear Energy Transfer","volume":"96","author":"Unkelbach","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"20190469","DOI":"10.1259\/bjr.20190469","article-title":"Is there a role for arcing techniques in proton therapy?","volume":"93","author":"Karagounis","year":"2020","journal-title":"Br. J. Radiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/mp.15276","article-title":"The current status of preclinical proton FLASH radiation and future directions","volume":"49","author":"Diffenderfer","year":"2022","journal-title":"Med. Phys."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2106\/JBJS.N.01141","article-title":"Prevalence of Total Hip and Knee Replacement in the United States","volume":"97","author":"Larson","year":"2015","journal-title":"J. Bone Jt. Surg. Am."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1118\/1.1565113","article-title":"Dosimetric considerations for patients with HIP prostheses undergoing pelvic irradiation. Report of the AAPM Radiation Therapy Committee Task Group 63","volume":"30","author":"Reft","year":"2003","journal-title":"Med. Phys."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"15330338211038490","DOI":"10.1177\/15330338211038490","article-title":"Evaluation of VMAT Planning Strategies for Prostate Patients with Bilateral Hip Prosthesis","volume":"20","author":"To","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.rpor.2015.03.006","article-title":"Volumetric modulated arc therapy in prostate cancer patients with metallic hip prostheses in a UK centre","volume":"20","author":"Ng","year":"2015","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13014-021-01975-3","article-title":"Radiotherapy-induced toxicity in prostate cancer patients with hip prostheses","volume":"17","author":"Fischer","year":"2022","journal-title":"Radiat. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.rpor.2013.03.006","article-title":"Volumetric modulated arc therapy for prostate cancer patients with hip prosthesis","volume":"18","author":"Prabhakar","year":"2013","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/jrr\/rrs101","article-title":"Anatomy-based volumetric modulated arc therapy for a prostate cancer patient with a hip prosthesis","volume":"54","author":"Kunishima","year":"2013","journal-title":"J. Radiat. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/2278-330X.126506","article-title":"A dosimetric study of volumetric modulated arc therapy planning techniques for treatment of low-risk prostate cancer in patients with bilateral hip prostheses","volume":"3","author":"Rana","year":"2014","journal-title":"South. Asian J. Cancer."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/0284186X.2017.1358463","article-title":"Have we reached proton beam therapy dosimetric limitations?\u2014A novel robust, delivery-efficient and continuous spot-scanning proton arc (SPArc) therapy is to improve the dosimetric outcome in treating prostate cancer","volume":"57","author":"Ding","year":"2018","journal-title":"Acta Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"20210670","DOI":"10.1259\/bjr.20210670","article-title":"Proton therapy for prostate cancer: Current state and future perspectives","volume":"95","author":"Wu","year":"2022","journal-title":"Br. J. Radiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.radonc.2019.04.032","article-title":"The first prototype of spot-scanning proton arc treatment delivery","volume":"137","author":"Li","year":"2019","journal-title":"Radiother. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7117","DOI":"10.1088\/0031-9155\/57\/21\/7117","article-title":"Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer","volume":"57","author":"Rechner","year":"2012","journal-title":"Phys. Med. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"109670","DOI":"10.1016\/j.radonc.2023.109670","article-title":"Proton arc therapy increases the benefit of proton therapy for oropharyngeal cancer patients in the model based clinic","volume":"184","author":"Korevaar","year":"2023","journal-title":"Radiother. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1120\/jacmp.v15i3.4611","article-title":"Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy","volume":"15","author":"Rana","year":"2014","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3109\/0284186X.2014.986288","article-title":"Anterior-oriented proton beams for prostate cancer: A multi-institutional experience","volume":"54","author":"Cuaron","year":"2015","journal-title":"Acta Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.14338\/IJPT-15-00015.1","article-title":"Anteriorly oriented beam arrangements with daily in vivo range verification for proton therapy of prostate cancer: Rectal toxicity rates","volume":"2","author":"Polf","year":"2016","journal-title":"Int. J. Part. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1088\/1361-6560\/62\/5\/1644","article-title":"Proton therapy of prostate cancer by anterior-oblique beams: Implications of setup and anatomy variations","volume":"62","author":"Moteabbed","year":"2017","journal-title":"Phys. Med. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/jrr\/rraa013","article-title":"Comparison of rectal dose reduction by a hydrogel spacer among 3D conformal radiotherapy, volumetric-modulated arc therapy, helical tomotherapy, CyberKnife and proton therapy","volume":"61","author":"Saito","year":"2020","journal-title":"J. Radiat. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.meddos.2020.11.007","article-title":"The robustness of prostate radiotherapy for patients with hip prosthesis","volume":"46","author":"Nadhum","year":"2021","journal-title":"Med. Dosim."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.meddos.2022.09.001","article-title":"Evaluation of RayStation\u2019s delivered dose and accumulated dose features for spine stereotactic radiotherapy","volume":"48","author":"Vaccarelli","year":"2023","journal-title":"Med. Dosim."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"R419","DOI":"10.1088\/0031-9155\/59\/22\/R419","article-title":"Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer","volume":"59","author":"Paganetti","year":"2014","journal-title":"Phys. Med. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"20160348","DOI":"10.1259\/bjr.20160348","article-title":"Simple diagrammatic method to delineate male urethra in prostate cancer radiotherapy: An MRI based approach","volume":"89","author":"Kataria","year":"2016","journal-title":"Br. J. Radiol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Pham, J., Savjani, R.R., Gao, Y., Cao, M., Hu, P., Sheng, K., Low, D.A., Steinberg, M., Kishan, A.U., and Yang, Y. (2021). Evaluation of T2-Weighted MRI for Visualization and Sparing of Urethra with MR-Guided Radiation Therapy (MRgRT) On-Board MRI. Cancers., 13.","DOI":"10.3390\/cancers13143564"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Lee, H., Shin, J., Verburg, J.M., Bobi\u0107, M., Winey, B., Schuemann, J., and Paganetti, H. (2022). MOQUI: An open-source GPU-based Monte Carlo code for proton dose calculation with efficient data structure. Phys. Med. Biol., 67.","DOI":"10.1088\/1361-6560\/ac8716"},{"key":"ref_37","unstructured":"(2023, August 05). The R Project for Statistical Computing. Available online: https:\/\/www.r-project.org."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.phro.2021.10.004","article-title":"Normal tissue complication probability models for prospectively scored late rectal and urinary morbidity after proton therapy of prostate cancer","volume":"20","author":"Pedersen","year":"2021","journal-title":"Phys. Imaging Radiat. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1084311","DOI":"10.3389\/fonc.2022.1084311","article-title":"Predictive modelling for late rectal and urinary toxicities after prostate radiotherapy using planned and delivered dose","volume":"12","author":"Ong","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"102644","DOI":"10.1016\/j.ejmp.2023.102644","article-title":"Bone marrow sparing in prostate cancer patients treated with Post-operative pelvic nodal radiotherapy\u2014A proton versus photon comparison","volume":"112","author":"Bossart","year":"2023","journal-title":"Phys. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1200\/jco.2011.29.7_suppl.100","article-title":"Safety of proton therapy treatment for prostate cancer patients with unilateral hip replacements","volume":"29","author":"Nichols","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1159\/000526932","article-title":"Carbon-Ion Radiotherapy Using Metal Artifact Reduction Computed Tomography in a Patient with Prostate Cancer with Bilateral Hip Prostheses: A Case Report","volume":"15","author":"Takakusagi","year":"2022","journal-title":"Case Rep. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1177\/0284185117751278","article-title":"Metal artifact reduction in CT, a phantom study: Subjective and objective evaluation of four commercial metal artifact reduction algorithms when used on three different orthopedic metal implants","volume":"59","author":"Bolstad","year":"2018","journal-title":"Acta Radiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/acm2.12277","article-title":"Assessment of multi-criteria optimization (MCO) for volumetric modulated arc therapy (VMAT) in hippocampal avoidance whole brain radiation therapy (HA-WBRT)","volume":"19","author":"Zieminski","year":"2018","journal-title":"J. Appl. Clin. Med. Phys."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/2\/330\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:45:00Z","timestamp":1760103900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/2\/330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["cancers16020330"],"URL":"https:\/\/doi.org\/10.3390\/cancers16020330","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,11]]}}}